ClinConnect ClinConnect Logo
Search / Trial NCT06939192

E-health-supported Diagnostic and Intervention in Preterm Born Children and Their Families

Launched by UNIVERSITY HOSPITAL TUEBINGEN · Apr 14, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Preterm Birth E Health Risk Factors Protective Factors Prevention

ClinConnect Summary

This clinical trial is studying a new way to support families with premature babies, specifically those born between 28 and 34 weeks of pregnancy. The researchers want to see if an app can help identify mental and physical health needs in these children and their families, aiming to improve care after they leave the hospital. Families will be divided into two groups: one that will use the app and another that will receive standard care.

To participate, mothers must be at least 18 years old, have internet access, and be able to communicate in German. Unfortunately, families with babies born before 28 weeks or after 34 weeks, or those with serious health issues, won't be eligible. If you join the study, you can expect support through the app, which focuses on strengthening your family's well-being during a challenging time. The trial is currently recruiting participants, and your involvement could contribute to better care for future families with premature babies.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Premature babies born at the UKT,
  • Gestational age 28-34 weeks,
  • Mother: age ≥ 18 years,
  • agreement to participate in this study and signing of a consent form,
  • sufficient knowledge of German,
  • internet access
  • Exclusion Criteria:
  • Premature babies \< 28th or \>34th week of pregnancy,
  • at least one of the children has serious diseases of the nervous system or obvious symptoms of a nervous disease,
  • at least one of the children has serious congenital diseases or suffers from malformations,
  • Mother: Lack of access to a smartphone/tablet,
  • no internet access,
  • insufficient knowledge of German

About University Hospital Tuebingen

University Hospital Tübingen is a leading academic medical institution in Germany, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital leverages its multidisciplinary expertise and cutting-edge facilities to develop new therapeutic strategies and improve patient outcomes. With a strong focus on translational medicine, University Hospital Tübingen collaborates with various stakeholders, including pharmaceutical companies and research organizations, to facilitate the efficient and ethical conduct of trials across a wide range of medical disciplines. Their dedication to patient-centered research and rigorous scientific standards positions them at the forefront of medical advancements.

Locations

Tuebingen, , Germany

Tuebingen, Baden Württemberg, Germany

Patients applied

0 patients applied

Trial Officials

Annette Conzelmann, Prof. Dr.

Principal Investigator

Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University of Tübingen

Annika K Alt

Study Chair

Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University of Tübingen

Tobias J Renner, Prof. Dr.

Principal Investigator

Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University of Tübingen

Axel Franz, Prof. Dr.

Study Chair

Neonatology, University of Tübingen

Mirja Quante, Dr.

Study Chair

Neonatology, University of Tübingen

Michaela Minarski, Dr.

Study Chair

Neonatology, University of Tübingen

Johanna Löchner, Prof. Dr.

Study Chair

Clinical Psychology, FAU Erlangen

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported